Literature DB >> 27341989

Standard human chorionic gonadotropin versus double trigger for final oocyte maturation results in different granulosa cells gene expressions: a pilot study.

Jigal Haas1, Libby Ophir2, Eran Barzilay2, Ronit Machtinger2, Yuval Yung2, Raoul Orvieto2, Ariel Hourvitz2.   

Abstract

OBJECTIVE: To investigate the messenger RNA (mRNA) expression of reproduction-related genes in granulosa cells (GCs) of patients triggered with hCG compared with patients triggered with GnRH agonist and hCG (double trigger) for final oocyte maturation.
DESIGN: Granulosa cells were obtained at the time of oocyte retrieval, and gene expression was analyzed using quantitative real-time polymerase chain reaction.
SETTING: Referral center. PATIENT(S): Fifteen women undergoing controlled ovarian hyperstimulation for IVF who received hCG for final follicular maturation and in a subsequent IVF cycle received double trigger. INTERVENTION(S): Granulosa cells collection. MAIN OUTCOME MEASURE(S): The expression of genes related to ovarian hyperstimulation syndrome, gap junction, and epidermal-like growth factor in GCs. RESULT(S): The mRNA expressions of amphiregulin (2.1 vs. 1, arbitrary unit) and epiregulin (2.5 vs. 1, arbitrary unit) were significantly higher in the double trigger group compared with the hCG group. We found no difference in luteinizing hormone receptor and follicle stimulating hormone receptor mRNA expressions between the two groups. Moreover, although the mRNA expression of pigment epithelium-derived factor (1.5 vs. 1, arbitrary unit) was significantly higher in the double trigger group, no between-group differences were observed in the expression of vascular endothelial growth factor and GnRH receptor. The mRNA expression of conexin43 in cumulus cells (0.7 vs. 1, arbitrary unit) was significantly lower in the double trigger group compared with the hCG group. CONCLUSION(S): Our findings suggest that the decreased expression of conexin43 and the increased expression of epiregulin and amphiregulin in the GCs from patients receiving the double trigger may explain the suggested improved oocyte and embryo quality related to the double triggering group.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Double trigger; GnRH agonist; final follicular maturation

Mesh:

Substances:

Year:  2016        PMID: 27341989     DOI: 10.1016/j.fertnstert.2016.06.002

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

Review 1.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

2.  Combined GnRH-agonist and human chorionic gonadotropin trigger improves ICSI cycle outcomes in patients with history of poor fertilization.

Authors:  Rony T Elias; Nigel Pereira; Lisa Artusa; Amelia G Kelly; Monica Pasternak; Jovana P Lekovich; Gianpiero D Palermo; Zev Rosenwaks
Journal:  J Assist Reprod Genet       Date:  2017-04-13       Impact factor: 3.412

3.  The in-vitro effect of gonadotropins' type and combination on Granulosa cells gene expressions.

Authors:  Yuval Yung; Adva Aizer; Sarah Tieb; Sharon Avhar Maydan; Ettie Maman; Lilach Marom Haham; Jigal Haas; Raoul Orvieto
Journal:  Reprod Biol Endocrinol       Date:  2022-09-24       Impact factor: 4.982

4.  Does gonadotropin-releasing hormone agonist cause luteolysis by inducing apoptosis of the human granulosa-luteal cells?

Authors:  Noa Gonen; Robert F Casper; Andrea Jurisicova; Yuval Yung; Moran Friedman-Gohas; Raoul Orvieto; Jigal Haas
Journal:  J Assist Reprod Genet       Date:  2021-05-24       Impact factor: 3.357

5.  Transcriptomic landscape of granulosa cells and peripheral blood mononuclear cells in women with PCOS compared to young poor responders and women with normal response.

Authors:  Mauro Cozzolino; Sonia Herraiz; Shiny Titus; Leah Roberts; Monica Romeu; Irene Peinado; Richard T Scott; Antonio Pellicer; Emre Seli
Journal:  Hum Reprod       Date:  2022-05-30       Impact factor: 6.353

6.  GnRH Agonist and hCG (Dual Trigger) Versus hCG Trigger for Final Oocyte Maturation in Expected Normal Responders With a High Immature Oocyte Rate: Study Protocol for a Randomized, Superiority, Parallel Group, Controlled Trial.

Authors:  Meng-Han Yan; Jing-Xian Cao; Jin-Wei Hou; Wen-Jing Jiang; Dan-Dan Wang; Zhen-Gao Sun; Jing-Yan Song
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-28       Impact factor: 5.555

7.  Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin-releasing hormone agonist for women undergoing fertility preservation.

Authors:  Yeon Hee Hong; Seul Ki Kim; Jung Ryeol Lee; Byung Chul Jee; Chang Suk Suh
Journal:  Reprod Med Biol       Date:  2022-02-04

Review 8.  Luteinizing Hormone Action in Human Oocyte Maturation and Quality: Signaling Pathways, Regulation, and Clinical Impact.

Authors:  Armando Arroyo; Beomsu Kim; John Yeh
Journal:  Reprod Sci       Date:  2020-01-06       Impact factor: 3.060

Review 9.  Influence of human chorionic gonadotrophin during ovarian stimulation: an overview.

Authors:  Johan Smitz; Peter Platteau
Journal:  Reprod Biol Endocrinol       Date:  2020-08-06       Impact factor: 5.211

10.  Dual Trigger for Final Follicular Maturation Improves Cumulative Live-Birth Rate in Ovarian Stimulation for Freeze-All In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles.

Authors:  Haiyan Zhu; Chenqiong Zhao; Yibin Pan; Hanjing Zhou; Xiaoying Jin; Wen Xu; Songying Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-19       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.